Detalles de la búsqueda
1.
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.
J Rheumatol
; 51(3): 305-312, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839812
2.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol
; 51(5): 529-537, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428964
3.
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
Ann Rheum Dis
; 82(4): 565-573, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36442978
4.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford)
; 2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070152
5.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Ann Rheum Dis
; 81(12): 1742-1749, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944947
6.
Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials.
Curr Treat Options Oncol
; 21(11): 87, 2020 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862317
7.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis
; 83(5): 680-682, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199795
8.
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease.
Semin Arthritis Rheum
; 64: 152312, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38056314
9.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol
; 6(1): e21-e30, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258675
10.
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
Semin Arthritis Rheum
; 64: 152335, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100899
11.
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
Clin Rheumatol
; 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38898318
12.
Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination.
Clin Rheumatol
; 42(6): 1695-1700, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36656454
13.
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications.
J Rheumatol
; 50(5): 697-703, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642428
14.
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.
Semin Arthritis Rheum
; 58: 152108, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36347211
15.
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
Semin Arthritis Rheum
; 63: 152286, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37913612
16.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Lancet Rheumatol
; 5(3): e139-e150, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844970
17.
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.
Sci Transl Med
; 15(712): eadf6598, 2023 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672567
18.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
medRxiv
; 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873462
19.
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.
Lancet Rheumatol
; 5(5): e274-e283, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37841635
20.
A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis.
Front Immunol
; 13: 890996, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35693829